Why MoonLake Immunotherapeutics Stock Wilted on Wednesday

25.06.26 01:49 Uhr

Werte in diesem Artikel
Aktien

19,90 USD -0,09 USD -0,45%

MoonLake Immunotherapeutics (NASDAQ: MLTX) clearly wasn't immune to negative investor sentiment on Wednesday. The clinical-stage biotech's equity slumped by almost 6% during that trading session, mainly due to a secondary share issue announced by the company. Late Tuesday night, MoonLake announced the pricing of the share issue, adding that it had been upsized. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Quelle: MotleyFool

Nachrichten zu MoonLake Immunotherapeutics